| Original language | English |
|---|---|
| Pages (from-to) | 1385-1387 |
| Number of pages | 3 |
| Journal | JACC: Cardiovascular Interventions |
| Volume | 13 |
| Issue number | 11 |
| DOIs | |
| State | Published - Jun 8 2020 |
Funding
Please note: Dr. Garcia has been a consultant for Surmodics, Osprey Medical, Medtronic, Edwards Lifesciences, and Abbott; and has received grant support from Edwards Lifesciences and the VA Office of Research and Development. Dr. Abbott has been a research consultant for Pfizer and Recor. Dr. Gafoor has been a consultant to Boston Scientific, Abbott Vascular, and Medtronic; and a proctor for Medtronic. Dr. Sorajja has been a consultant for Abbott, Medtronic, Edwards Lifesciences, Boston Scientific, Gore, Pipeline Technologies, and Admedus; has been a speaker for Abbott and Medtronic; has received research funding from Abbott, Medtronic, Edwards Lifesciences, Boston Scientific; and holds equity in Pipeline Technologies and Admedus. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
| Funders | Funder number |
|---|---|
| Surmodics Incorporated | |
| Abbott Laboratories | |
| Medtronic | |
| Biomedical Laboratory Research and Development, VA Office of Research and Development | |
| Edwards Lifesciences | |
| Boston Scientific Neuromodulation Corporation | |
| Osprey Medical |
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine